Article
Hepatitis E: Update on Prevention and Control.
BioMed research international - 1 Jan 2018
Melgaço Juliana Gil, Gardinali Noemi Rovaris, de Mello Vinicius da Motta, Leal Mariana, Lewis-Ximenez Lia Laura, Pinto Marcelo Alves
Abstract excerpt
Hepatitis E virus (HEV) is a common etiology of acute viral hepatitis worldwide. Recombinant HEV vaccines have been developed, but only one is commercially available and licensed in China since 2011. Epidemiological studies have identified genotype 3 as the major cause of chronic infection in immunocompromised individuals. Ribavirin has been shown to be effective as a monotherapy to induce HEV clearance in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
